Paraganglioma

general

A neoplasm arising from paraganglia located along the sympathetic or parasympathetic nerves. Infrequently, it may arise outside the usual distribution of the sympathetic and parasympathetic paraganglia. Tumors arising from the adrenal gland medulla are called pheochromocytomas. Morphologically, paragangliomas usually display a nesting (Zellballen) growth pattern. There are no reliable morphologic criteria to distinguish between benign and malignant paragangliomas. The only definitive indica

68

Centers

76

Active Trials

$1.2B

Cancer Funding

Specific Cancer Types(3)

Top Centers for Paraganglioma(68)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
69.6
2
NCI Comprehensive
Active Research Program
69.6
3
NCI Comprehensive
Active Research Program
69.6
4
NCI Comprehensive
Active Research Program
69.6
5
NCI Clinical
Active Research Program
69.6
6
Active Research Program
69.6
7
NCI Comprehensive
Active Research Program
69.0
8
NCI Comprehensive
Active Research Program
68.5
9
NCI Comprehensive
Active Research Program
68.0
10
NCI Clinical
Active Research Program
66.9
11
NCI Comprehensive
Active Research Program
66.4
12
NCI Comprehensive
Active Research Program
50.2
13
NCI Comprehensive
Active Research Program
50.2
14
NCI Comprehensive
Active Research Program
50.2
15
NCI Comprehensive
Active Research Program
50.2
16
NCI Comprehensive
Active Research Program
50.2
17
NCI Comprehensive
Active Research Program
50.2
18
NCI Comprehensive
Active Research Program
50.2
19
NCI Comprehensive
Active Research Program
50.2
20
NCI Comprehensive
Active Research Program
50.2
21
NCI Comprehensive
Active Research Program
50.2
22
NCI Comprehensive
Active Research Program
50.2
2350.2
24
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
50.2
25
NCI Comprehensive
Active Research Program
50.2
26
NCI Comprehensive
Active Research Program
50.2
27
NCI Comprehensive
Active Research Program
50.2
28
NCI Comprehensive
Active Research Program
50.2
29
NCI Comprehensive
Active Research Program
50.2
30
NCI Comprehensive
Active Research Program
50.2
31
NCI Comprehensive
Active Research Program
50.2
32
NCI Comprehensive
Active Research Program
50.2
33
Active Research Program
50.2
34
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
50.2
35
NCI Comprehensive
Active Research Program
50.2
36
Active Research Program
50.2
37
NCI Clinical
Active Research Program
50.2
38
NCI Comprehensive
Active Research Program
50.2
39
NCI Comprehensive
Active Research Program
50.2
40
NCI Comprehensive
Active Research Program
50.2
41
NCI Clinical
Active Research Program
50.2
42
NCI Comprehensive
Active Research Program
50.2
43
Active Research Program
50.2
44
NCI Comprehensive
Active Research Program
50.2
4550.2
46
Active Research Program
50.2
47
Active Research Program
50.2
48
Active Research Program
50.2
49
NCI Basic_laboratory
Active Research Program
50.2
50
Active Research Program
50.2
51
Active Research Program
50.2
52
Active Research Program
50.2
53
Active Research Program
50.2
54
Active Research Program
50.2
55
Active Research Program
50.2
56
BC CancerVancouver, BC
Active Research Program
50.2
57
Active Research Program
50.2
58
NCI Comprehensive
Active Research Program
47.0
59
NCI Comprehensive
29.7
60
NCI Comprehensive
29.7
61
NCI Comprehensive
29.7
62
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
29.7
6329.7
6429.7
6529.7
6629.7
67
NCI Comprehensive
68

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →